Detalles de la búsqueda
1.
Waldenström's macroglobulinemia: a clinical perspective in the era of novel therapeutics.
Ann Oncol
; 27(2): 233-40, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26598544
2.
Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol
; 30(5): 860-862, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30520968
3.
Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents.
Ann Oncol
; 25(1): 195-200, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24356630
4.
Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol
; 29(Suppl 4): iv270, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30285219
5.
Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol
; 29(Suppl 4): iv41-iv50, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29982402
6.
Report of consensus panel 2 from the 11th international workshop on Waldenström's macroglobulinemia on the management of relapsed or refractory WM patients.
Semin Hematol
; 60(2): 80-89, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37147252
7.
Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy.
Ann Oncol
; 23(10): 2681-2686, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22492699
8.
The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal function.
Ann Oncol
; 23(3): 722-729, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21652580
9.
Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid.
Ann Oncol
; 20(1): 117-20, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18689864
10.
Microvessel density (MVD) and cyclooxygenase-2 (COX-2)/ beta-catenin interaction are associated with relapse in patients with transitional carcinoma receiving adjuvant chemotherapy with paclitaxel/carboplatin: a hellenic cooperative oncology group (HECOG) study.
Anticancer Res
; 28(4C): 2479-86, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18751438
11.
Anthracycline-based adjuvant chemotherapy in early-stage uterine sarcomas: long-term results of a single institution experience.
Eur J Gynaecol Oncol
; 28(2): 109-16, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17479671
12.
Low circulating mannan-binding lectin levels correlate with increased frequency and severity of febrile episodes in myeloma patients who undergo ASCT and do not receive antibiotic prophylaxis.
Bone Marrow Transplant
; 52(11): 1537-1542, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28805791
13.
Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomib.
Blood Cancer J
; 7(6): e570, 2017 06 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-28622303
14.
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study.
Leukemia
; 31(11): 2443-2448, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28620163
15.
Carcinomatous meningitis from transitional cell carcinoma of the urinary bladder.
J BUON
; 16(2): 373-4, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21766515
16.
Increased circulating VCAM-1 correlates with advanced disease and poor survival in patients with multiple myeloma: reduction by post-bortezomib and lenalidomide treatment.
Blood Cancer J
; 6: e428, 2016 05 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-27232930
17.
High levels of periostin correlate with increased fracture rate, diffuse MRI pattern, abnormal bone remodeling and advanced disease stage in patients with newly diagnosed symptomatic multiple myeloma.
Blood Cancer J
; 6(10): e482, 2016 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27716740
18.
Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group.
J Clin Oncol
; 22(11): 2150-4, 2004 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15169801
19.
Carboplatin hypersensitivity reactions: a single institution experience.
J Chemother
; 17(1): 104-10, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15828452
20.
Adjuvant chemotherapy with paclitaxel and carboplatin in non-endometrioid carcinoma of the uterus.
Eur J Gynaecol Oncol
; 26(6): 627-31, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16398224